Beacon Pointe Advisors, LLC Novartis Ag Transaction History
Beacon Pointe Advisors, LLC
- $8.35 Billion
- Q2 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 45,923 shares of NVS stock, worth $5.31 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
45,923
Previous 44,714
2.7%
Holding current value
$5.31 Million
Previous $4.33 Million
13.02%
% of portfolio
0.06%
Previous 0.05%
Shares
18 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$857 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$856 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$687 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...